Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

USA - NASDAQ:OSUR - US68554V1089 - Common Stock

2.97 USD
-0.07 (-2.3%)
Last: 10/21/2025, 1:17:55 PM
Fundamental Rating

2

Taking everything into account, OSUR scores 2 out of 10 in our fundamental rating. OSUR was compared to 190 industry peers in the Health Care Equipment & Supplies industry. While OSUR seems to be doing ok healthwise, there are quite some concerns on its profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OSUR had negative earnings in the past year.
OSUR had a negative operating cash flow in the past year.
OSUR had negative earnings in 4 of the past 5 years.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

OSUR has a Return On Assets of -11.47%. This is comparable to the rest of the industry: OSUR outperforms 57.89% of its industry peers.
OSUR's Return On Equity of -13.40% is fine compared to the rest of the industry. OSUR outperforms 62.63% of its industry peers.
Industry RankSector Rank
ROA -11.47%
ROE -13.4%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

The Gross Margin of OSUR (40.49%) is worse than 66.32% of its industry peers.
OSUR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
OSUR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OSUR has been increased compared to 5 years ago.
Compared to 1 year ago, OSUR has an improved debt to assets ratio.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.24 indicates that OSUR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.24, OSUR is doing good in the industry, outperforming 62.11% of the companies in the same industry.
OSUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
OSUR has a Debt to Equity ratio of 0.00. This is in the better half of the industry: OSUR outperforms 75.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACCN/A
WACC8.65%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 7.12 indicates that OSUR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.12, OSUR belongs to the best of the industry, outperforming 86.32% of the companies in the same industry.
A Quick Ratio of 6.33 indicates that OSUR has no problem at all paying its short term obligations.
OSUR has a Quick ratio of 6.33. This is amongst the best in the industry. OSUR outperforms 87.37% of its industry peers.
Industry RankSector Rank
Current Ratio 7.12
Quick Ratio 6.33
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -286.11%.
Looking at the last year, OSUR shows a very negative growth in Revenue. The Revenue has decreased by -49.36% in the last year.
OSUR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.75% yearly.
EPS 1Y (TTM)-286.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2500%
Revenue 1Y (TTM)-49.36%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-42.5%

3.2 Future

The Earnings Per Share is expected to grow by 25.37% on average over the next years. This is a very strong growth
Based on estimates for the next years, OSUR will show a decrease in Revenue. The Revenue will decrease by -4.62% on average per year.
EPS Next Y-229.54%
EPS Next 2Y-60.3%
EPS Next 3Y-28.43%
EPS Next 5Y25.37%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

OSUR's earnings are expected to decrease with -28.43% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-60.3%
EPS Next 3Y-28.43%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (10/21/2025, 1:17:55 PM)

2.97

-0.07 (-2.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners92.79%
Inst Owner Change-0.18%
Ins Owners4.8%
Ins Owner Change8.23%
Market Cap217.23M
Analysts82.5
Price Target6.12 (106.06%)
Short Float %5.59%
Short Ratio6.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.39%
Min EPS beat(2)-24.34%
Max EPS beat(2)-0.43%
EPS beat(4)1
Avg EPS beat(4)-35.92%
Min EPS beat(4)-142.2%
Max EPS beat(4)23.28%
EPS beat(8)4
Avg EPS beat(8)-43.86%
EPS beat(12)8
Avg EPS beat(12)205%
EPS beat(16)8
Avg EPS beat(16)106.42%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)0.89%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)10.24%
Revenue beat(16)15
Avg Revenue beat(16)9.83%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)-17.65%
EPS NY rev (1m)-12.75%
EPS NY rev (3m)-12.75%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-14.74%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-5.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.57
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.89
BVpS5.21
TBVpS4.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.47%
ROE -13.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.19%
Cap/Sales 2.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.12
Quick Ratio 6.33
Altman-Z 2.24
F-Score3
WACC8.65%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-286.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2500%
EPS Next Y-229.54%
EPS Next 2Y-60.3%
EPS Next 3Y-28.43%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-49.36%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-42.5%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
EBIT growth 1Y-528.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100.55%
EBIT Next 3Y14.36%
EBIT Next 5Y25.91%
FCF growth 1Y-140.24%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-127.86%
OCF growth 3YN/A
OCF growth 5Y22.81%